Literature DB >> 21114786

Complementary and alternative medicine practices among Asian radiotherapy patients.

Lea Choung Wong1, Edwin Chan, Sharon Tay, Khai Mun Lee, Michael Back.   

Abstract

AIM: To describe the prevalence, expectations and factors associated with the use of complementary and alternative medicine (CAM) in Asian radiotherapy patients.
METHODS: Overall 65 consecutive patients in an Asian oncology department were surveyed from December 2004 to January 2005, using a modified and translated instrument capturing information on patients' characteristics, CAM use, treatment refusal and satisfaction.
RESULTS: Some basic characteristics were: 86% Chinese; median age 56 years (range: 31-87 years); 57% women; cancer types - breast 42%, lung 20%, nasopharyngeal 11%. All had received prior radiotherapy (54%), chemotherapy (51%) or surgery (45%). The median diagnosis-to-survey time was 7.1 months (range 1-168 months). Fifty-six patients (86%) used CAM for cancer treatment. The two commonest categories were spiritual practices (48%) and traditional Chinese medicine (TCM) (37%). Significant factors in TCM use were being male (P = 0.007) and having advanced disease (P = 0.045). Overall 60% of patients using herbal treatment and 97% of patients using spiritual practices expected a cure, a longer life, symptomatic relief, improved immunity or a better quality of life. Satisfaction with western treatment correlated positively with satisfaction with CAM (Spearman's rank correlation coefficient = 0.4). Forty-six patients (71%) did not discuss their CAM use with their oncologists and 64% obtained advice from their friends or families. Fourteen patients refused previous western treatments (11 feared its side effects (79%), five preferred CAM (36%)).
CONCLUSION: This study highlights the prevalence of CAM practices among Asian radiotherapy patients, their high expectations of the outcome and the need for better doctor-patient communication.
© 2010 Blackwell Publishing Asia Pty Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21114786     DOI: 10.1111/j.1743-7563.2010.01296.x

Source DB:  PubMed          Journal:  Asia Pac J Clin Oncol        ISSN: 1743-7555            Impact factor:   2.601


  11 in total

1.  Complementary and alternative medicine use and disclosure amongst Australian radiotherapy patients.

Authors:  Darren Hunter; Richard Oates; Janet Gawthrop; Michelle Bishop; Suki Gill
Journal:  Support Care Cancer       Date:  2014-01-19       Impact factor: 3.603

2.  Improved Aitongxiao prescription (I-ATXP) induces apoptosis, cell cycle arrest and blocks exosomes release in hepatocellular carcinoma (HCC) cells.

Authors:  Ming-Bo Huang; Zhao Gao; Meng Xia; Xiaoqing Zhao; Xiaoyuan Fan; Shijie Lin; Lifeng Zhang; Li Huang; Ailing Wei; Hu Zhou; Jennifer Y Wu; William W Roth; Vincent C Bond; Jing Leng
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2022-04-15

3.  Complementary and alternative medicine use and breast cancer prognosis: a pooled analysis of four population-based studies of breast cancer survivors.

Authors:  Rayna Kim Matsuno; Ian S Pagano; Gertraud Maskarinec; Brian F Issell; Carolyn C Gotay
Journal:  J Womens Health (Larchmt)       Date:  2012-10-17       Impact factor: 2.681

4.  Patient-physician communication about complementary and alternative medicine in a radiation oncology setting.

Authors:  Jin Ge; Jessica Fishman; Neha Vapiwala; Susan Q Li; Krupali Desai; Sharon X Xie; Jun J Mao
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-10-03       Impact factor: 7.038

5.  Complementary therapy use in metropolitan and regional Australian radiotherapy centres; do patients report effective outcomes?

Authors:  Darren Hunter; Christopher Marinakis; Ruth Salisbury; Alison Cray; Richard Oates
Journal:  Support Care Cancer       Date:  2015-10-08       Impact factor: 3.603

6.  Expectations from an integrative medicine consultation in breast cancer care: a registry protocol-based study.

Authors:  Noah Samuels; Elad Schiff; Ofer Lavie; Orit Gressel Raz; Eran Ben-Arye
Journal:  Support Care Cancer       Date:  2014-07-30       Impact factor: 3.603

Review 7.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

Review 8.  Chinese medicines induce cell death: the molecular and cellular mechanisms for cancer therapy.

Authors:  Xuanbin Wang; Yibin Feng; Ning Wang; Fan Cheung; Hor Yue Tan; Sen Zhong; Charlie Li; Seiichi Kobayashi
Journal:  Biomed Res Int       Date:  2014-10-14       Impact factor: 3.411

Review 9.  Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.

Authors:  Grayson A Roumeliotis; Genevieve Dostaler; Kirsty U Boyd
Journal:  Plast Surg (Oakv)       Date:  2017-08-22       Impact factor: 0.947

10.  International Survey on the Use of Complementary and Alternative Medicines for Common Toxicities of Radiation Therapy.

Authors:  Anna Lee; Aleksandra Kuczmarska-Haas; Meghan W Macomber; Kaitlin Woo; Chris Freese; Zachary S Morris
Journal:  Adv Radiat Oncol       Date:  2018-10-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.